Research and Markets: Global Genetic Testing Market 2015 Report With Forecasts to 2019

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/gd6tc8/global_genetic) has announced the addition of the "Global Genetic Testing Market 2015-2019" report to their offering.

Consumers who are not benefiting from general medicine can undergo personalized treatment based on a study of their genomic sequence. Personalized medicine uses molecular markers to identify disease risk or occurrence before the appearance of clinical symptoms. It also offers the chance to focus on prevention and early treatment rather than on reaction to the advanced stages of a disease. For instance, in breast cancer, BRCA1 and BRCA2 genetic tests are used to guide preventive measures. With the completion of the human genome project and advances in genomics, proteomics, and metabolomics, consumers are moving toward personalized medicine. Thus, growing demand for personalized medicine will have a positive impact on the market.

According to the report, the global genetic testing market will grow at a CAGR of 9.65% over the period 2014-2019. Down's syndrome, sickle cell anemia, and cystic fibrosis are some of the genetic disorders caused by the presence of a gene mutation. According to the World Health Organization, the global prevalence of all single-gene diseases at birth is approximately 10 per 1,000 births. Sickle cell anemia is one of the examples of a genetic disease that affects millions worldwide. In the US alone, it affects around 72,000 people every year, and over 300,000 babies with severe hemoglobin disorders are born each year. Thus, the rise in the incidence of genetic diseases will drive the global genetic testing market.

Key Topics Covered

  1. Executive Summary
  2. List of Abbreviations
  3. Scope of the Report
  4. Market Research Methodology
  5. Introduction
  6. Market Landscape
  7. Market Segmentation by Application
  8. Regulation of Genetic Testing
  9. DTC Genetic Testing
  10. Geographical Segmentation
  11. Buying Criteria
  12. Market Growth Drivers
  13. Drivers and their Impact
  14. Market Challenges
  15. Impact of Drivers and Challenges
  16. Market Trends
  17. Trends and their Impact
  18. Vendor Landscape
  19. Key Vendor Analysis

Companies Mentioned

  • Abbott Laboratories
  • Biocartis
  • BioMerieux
  • BioRad Laboratories
  • Cepheid
  • EKF Diagnostics
  • Elitech
  • IntegraGen
  • Interpace Diagnostics
  • Luminex
  • Myriad Genetics
  • PerkinElmer
  • Qiagen
  • Quest Diagnostics
  • Roche Diagnostics
  • Seegene
  • WaferGen Biosystems

For more information visit http://www.researchandmarkets.com/research/gd6tc8/global_genetic

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Diagnostics

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Diagnostics